Can we prevent or treat renal dysfunction in acute heart failure?

Area of Science:

• Nephrology
• Cardiology
• Pharmacology

Background:

• Renal dysfunction is common in heart failure (HF) patients and linked to poor prognosis.
• HF treatments, including high-dose furosemide, can exacerbate renal function.
• Existing therapies like vasopressin and adenosine antagonists have not improved HF outcomes.

Purpose of the Study:

• To review strategies for detecting renal dysfunction in acute HF.
• To elucidate the pathophysiological mechanisms of renal dysfunction in acute HF.
• To discuss potential therapeutic approaches for renal dysfunction in acute HF.

Main Methods:

• Literature review of studies on renal dysfunction in acute heart failure.
• Analysis of pathophysiological mechanisms linking HF and renal impairment.
• Evaluation of current and emerging treatment strategies for renal dysfunction in HF.

Main Results:

• Transient worsening renal function (WRF) during acute HF treatment may not always indicate a poor prognosis.
• Aggressive fluid removal can benefit HF patients with fluid overload, despite potential WRF.
• Current interventions targeting renal blood flow (dopamine, inotropes, vasodilators) lack clear benefits.

Conclusions:

• Accurate detection of renal dysfunction is crucial in acute HF management.
• Understanding pathophysiological links is key to developing effective treatments.
• Further research is needed for novel therapeutic strategies to improve renal outcomes in HF.